SMALL MOLECULE MODULATORS OF IL-17

The present invention relates to a compound according to formula (I), and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e...

Full description

Saved in:
Bibliographic Details
Main Authors LARSEN, Mogens, ANDERSEN, Peter, SEITZBERG, Jimmi Gerner, LIANG, Xifu, ANDREWS, Mark, DACK, Kevin Neil, NOERRESKOV BURHARDT, Mia
Format Patent
LanguageEnglish
French
Published 22.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a compound according to formula (I), and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments. La présente invention concerne un composé selon la formule (I) et des sels, hydrates ou solvates pharmaceutiquement acceptables de celui-ci. L'invention concerne en outre lesdits composés destinés à être utilisés en thérapie, des compositions pharmaceutiques comprenant lesdits composés, des procédés de traitement de maladies, par exemple des maladies dermiques, avec lesdits composés, et l'utilisation desdits composés dans la fabrication de médicaments.
Bibliography:Application Number: WO2022EP86153